Bromodrol, Dual Action Grow Tabs, Grow Tabs, Mass Tabs, Ripped Tabs TR Recalled

IDS Sports is recalling five of its dietary supplement products.
The recalled products were sold under the following names: Bromodrol, Dual Action Grow Tabs, Grow Tabs, Mass Tabs and Ripped Tabs TR.

The FDA has notified IDS Sports that the recalled products contain the following undeclared substances, which FDA considers to be steroids: madol, turinabol, superdrol and androstenedione.

Acute liver injury is known to be a possible harmful effect of using steroid-containing products. In addition, steroids may cause other serious long-term adverse health consequences in men, women and children. These health issues include shrinkage of the testes and male infertility, masculinization of women, breast enlargement in males, short stature in children, a higher predilection to misuse other drugs and alcohol, adverse effects on blood lipid levels and increased risk of heart attack, stroke and death.

The recalled products listed below were distributed in either black boxes containing blister packs of 60 capsules or white bottles with black labels containing 30 or 60 capsules:

• Bromodrol
• • UPC: 6 75941 00250 7
  • All lots
• Dual Action Grow Tabs
• • UPC: 6 75941 00252 1
  • All lots
• Grow Tabs
• • UPC: 6 75941 00252 1
  • All lots
• Mass Tabs
• • UPC: 6 75941 00149 4
  • Lots purchased during or after 4/09
• Mass Tabs
• • UPC: 6 75941 00149 4
  • Lots purchased during or after 8/09
• Ripped Tabs
• • UPC: 6 75941 00162 3
  • Lots purchased during or after 12/08
• Ripped Tabs TR
• • UPC: 6 75941 00162 3
  • Lots purchased during or after 12/08

Although no illnesses or adverse events have been reported to the company to date in connection with the products listed above, customers who have these products in their possession should stop using them immediately and contact their physician if they have experienced any problems that may be related to using one or more of the products.

Any adverse events that may be related to using these products should be reported to the FDA's MedWatch Adverse Event Reporting program:

• Online: www.fda.gov/MedWatch/report.htm
• By postal mail: Return postage-paid FDA form 3500 to MedWatch, 5600 Fishers Lane, Rockville, MD 20852-9787
• By fax: 800-FDA-0178

Contact:
Dave Dixon
888-795-0444